Filter
544
Filtered Results: 544
Text search:
TB
comorbidities
Featured
Recommendations
73
New Publications
129
Language
Document type
No document type
305
Guidelines
102
Studies & Reports
82
Strategic & Response Plan
21
Manuals
15
Training Material
7
Fact sheets
5
Infographics
4
Situation Updates
2
Resource Platforms
1
Countries / Regions
India
23
South Africa
22
Kenya
21
Global
18
Western and Central Europe
17
Africa
14
Latin America and the Carribbean
13
Ethiopia
12
Uganda
10
Ghana
9
Rwanda
9
Tanzania
9
Eastern Europe
8
Namibia
8
Senegal
7
Congo, Democratic Republic of
7
Zambia
7
Nepal
6
Asia
6
South–East Asia Region
6
Bangladesh
6
Brazil
6
Ukraine
5
Nigeria
5
Sierra Leone
4
Malawi
4
Myanmar / Burma
4
Eswatini/ Swaziland
4
Lesotho
3
Burkina Faso
3
Zimbabwe
3
Cambodia
3
Russia
3
Georgia
3
Tajikistan
2
Colombia
2
Laos
2
Peru
2
Philippines
2
Germany
2
West and Central Africa
2
Western Pacific Region
2
East and Southern Africa
2
Argentina
2
Vietnam
2
Romania
2
Botswana
2
Liberia
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Chile
1
Cameroon
1
Syria
1
Estonia
1
Burundi
1
Guinea
1
Venezuela
1
Middle East and North Africa
1
Paraguay
1
Gabon
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Central African Republic
1
Mali
1
South Sudan
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
206
Clinical Guidelines
80
Public Health
21
Capacity Building
3
Key Resources
3
Women & Child Health
2
Pharmacy & Technologies
1
Toolboxes
TB
161
HIV
105
COVID-19
45
Mental Health
14
NCDs
13
AMR
13
NTDs
9
Refugee
8
Ebola & Marburg
4
Pharmacy
4
Health Financing Toolbox
4
Conflict
4
Rapid Response
3
Caregiver
3
Polio
3
Disability
2
Cholera
1
This UNAIDS 2024 report brings together new data and case studies which demonstrate that the decisions and policy choices taken by world leaders this year will decide the fate of millions of lives and whether the world’s deadliest pandemic is overcome.
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Global HIV Strategic Information Working Group
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
A Provisional Document. The purpose of this manual is to provide guidance to public health professionals tasked with managing a response to viral hepatitis. As every country’s needs are different with respect to its epidemiology and the current level of response, people would use this manual in di...
Infection Prevention and Control Programmes
January 2020
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis ...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Guidelines
June 2017
HIV strategic information for impact
The World Health Organization's fourth Country Cooperation Strategy 2022-2026 is an outcome of a consultative process with inputs from the Ministry of Health, various agencies in the health sector, and other relevant stakeholders. It has been developed to provide strategic direction and support towa...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
Namibia is no exception to the growingglobal concern on the increasing burden of NCDs. Namibia is an upper middle income country with fast economic growth since independence in 1990. The country is bearing the double burden of communicable and noncommunicable diseases and rapid urbanizat...
Guidelines for the treatment of human African trypanosomiasis. Web Annex A. Commissioned by WHO Cochrane Response
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
